Global Radiotherapy Market Size, Share, Trends and Forecasts 2031

Key Findings

• Radiotherapy is a cornerstone cancer treatment modality, utilizing high-energy radiation to destroy or damage malignant cells while preserving healthy tissue.

• Technological advancements in image-guided radiotherapy (IGRT), proton therapy, and adaptive radiotherapy are enhancing precision and patient outcomes.

• Rising global cancer prevalence, especially breast, prostate, and lung cancers, is fueling demand for both external beam and internal radiotherapy systems.

• Linear accelerators (LINACs) dominate the external beam therapy market, with stereotactic radiosurgery (SRS) and intensity-modulated radiotherapy (IMRT) gaining adoption.

• Software innovations like real-time tumor tracking and artificial intelligence (AI)-assisted planning are becoming critical enablers of treatment accuracy.

• Hospitals and cancer care centers are leading end-users, while ambulatory radiotherapy clinics are emerging due to growing outpatient demand.

• North America and Europe are mature markets, but Asia-Pacific is witnessing the fastest growth due to healthcare infrastructure expansion and rising cancer awareness.

• High treatment cost and infrastructure requirements remain barriers, particularly in low- and middle-income countries.

• Key players include Varian Medical Systems, Elekta AB, Accuray Inc., IBA Group, and Mevion Medical Systems.

• Growing public-private partnerships and government funding initiatives are accelerating radiotherapy equipment installations across emerging economies.

Market Overview

The radiotherapy market has become a vital component of the global oncology landscape, providing clinicians with targeted, effective tools to manage and treat cancer. Radiotherapy encompasses a wide range of technologies, including external beam radiation therapy (EBRT), brachytherapy, and systemic radiotherapy. These modalities use ionizing radiation to eliminate cancerous tissues, often in conjunction with surgery and chemotherapy.

Modern radiotherapy is characterized by its growing precision and reduced side effects, driven by innovations in medical imaging, robotics, and treatment planning. Treatment techniques such as IMRT, VMAT (Volumetric Modulated Arc Therapy), and SBRT (Stereotactic Body Radiation Therapy) enable highly localized dose delivery. Meanwhile, particle therapy, particularly proton and carbon ion therapy, is setting new benchmarks for pediatric and complex cancers.

The integration of radiotherapy with digital health solutions, such as AI-powered planning, remote treatment verification, and cloud-based workflow systems, is also reshaping cancer care. The market is supported by increasing investments in cancer research, public awareness programs, and growing access to insurance in key developing markets.

Radiotherapy Market Size and Forecast

The global radiotherapy market was valued at USD 8.4 billion in 2024 and is projected to reach USD 16.1 billion by 2031, expanding at a CAGR of 9.8% during the forecast period.

Market growth is primarily driven by the surging global cancer incidence, technological innovation, and rising adoption of advanced radiotherapy techniques. Government-sponsored cancer control programs, especially in Asia and Latin America, are enabling new infrastructure development and equipment procurement. Furthermore, hybrid therapy models combining radiotherapy with immunotherapy are gaining research traction, adding new dimensions to market potential.

Despite strong demand, the market faces challenges such as high equipment costs, long installation cycles, and a shortage of trained radiation oncologists. However, mobile radiotherapy units and simplified user interfaces are helping bridge the treatment access gap in rural and underserved areas.

Future Outlook

The radiotherapy market is poised for a transformation driven by personalization, digitization, and automation. In the next 5–7 years, the convergence of advanced imaging, AI-assisted planning, and robotic patient positioning will redefine treatment workflows and improve precision.

Proton therapy centers are expected to proliferate, especially in Asia-Pacific and the Middle East, while compact and low-cost proton systems will expand access in mid-sized healthcare facilities. Adaptive radiotherapy, where treatment plans are adjusted in real-time based on anatomical changes, will become standard in major oncology centers.

Digital twins for patient simulation, cloud-based oncology ecosystems, and real-time dosimetry are set to become integral to the next generation of radiotherapy. Moreover, increased global funding for cancer treatment infrastructure, particularly through public-private partnerships, will be instrumental in expanding the reach of radiotherapy to underserved populations.

Radiotherapy Market Trends

• Proliferation of Proton Therapy:
  Proton therapy is rapidly gaining attention for its ability to deliver targeted radiation with minimal exit dose, making it ideal for pediatric and sensitive-area tumors. Cost reduction in equipment and modular center design is driving its adoption beyond large academic hospitals into regional treatment centers.

• AI and Machine Learning in Treatment Planning:
  Artificial intelligence is revolutionizing radiotherapy planning by enabling automatic contouring, dose optimization, and adaptive scheduling. These technologies not only reduce planning time but also enhance consistency and accuracy across large patient volumes, improving overall care quality.

• Growing Use of Adaptive Radiotherapy:
  Adaptive radiotherapy is transforming treatment by allowing adjustments to radiation delivery in response to daily changes in patient anatomy or tumor movement. Real-time imaging integration is making this approach more feasible, especially in tumors near critical structures.

• Robotics in Patient Positioning:
  Robotic systems are increasingly being used to ensure millimeter-level patient alignment, reducing human error and setup time. These platforms are especially valuable in stereotactic treatments, where precision targeting is essential for outcomes and safety.

• Rise of Outpatient Radiotherapy Clinics:
  With rising demand for convenience and cost-effective care, outpatient radiotherapy centers are growing rapidly. These clinics are equipped with compact LINACs and streamlined software to deliver efficient treatment, making them attractive alternatives to hospital-based care.

Market Growth Drivers

• Rising Global Cancer Burden:
  The increasing incidence of cancer worldwide—driven by aging populations, lifestyle changes, and improved diagnostics—is the most fundamental growth driver for the radiotherapy market. Cancers such as breast, lung, and prostate, which respond well to radiotherapy, are particularly on the rise.

• Technological Advancements in Radiotherapy Systems:
  Continuous innovation in imaging, beam modulation, and treatment delivery has dramatically improved the safety, speed, and effectiveness of radiotherapy. Technologies such as real-time MRI-guided systems and FLASH therapy are opening new clinical possibilities.

• Government Investment and Reimbursement Support:
  Many countries are expanding public funding for cancer infrastructure, including radiotherapy machines. Reimbursement schemes for advanced treatments, especially in North America and parts of Europe and Asia, are making radiotherapy more accessible to a broader population.

• Integration of Radiotherapy with Digital Platforms:
  Cloud-based treatment planning systems and digital workflows are enhancing collaboration among oncologists, radiologists, and technicians. These systems facilitate precision, reduce planning time, and allow remote quality assurance, significantly improving operational efficiency.

• Public-Private Collaborations for Cancer Infrastructure:
  Partnerships between governments, hospitals, and private companies are enabling the development of state-of-the-art cancer treatment centers. These collaborations often include long-term procurement contracts and technology training, driving equipment sales and adoption.

Challenges in the Market

• High Equipment and Installation Costs:
  Radiotherapy equipment, particularly particle therapy systems and image-guided platforms, require multimillion-dollar investments and specialized construction. This makes access difficult for hospitals in low-income regions and slows overall market penetration.

• Shortage of Skilled Personnel:
  Operating modern radiotherapy systems requires trained radiation oncologists, physicists, and technologists. Many regions, especially in emerging markets, lack sufficient trained professionals, leading to underutilization of installed equipment and reduced treatment capacity.

• Infrastructure and Maintenance Barriers:
  Radiotherapy systems demand reliable power, shielding infrastructure, and ongoing maintenance. Infrastructural deficiencies in developing regions hinder equipment deployment and may compromise treatment continuity due to frequent breakdowns.

• Stringent Regulatory and Licensing Processes:
  Radiotherapy equipment is subject to rigorous safety, quality, and radiation compliance standards. The complexity and time required for regulatory approvals can delay product launch and installation, especially for new technologies.

• Disparity in Access to Care:
  Even in developed countries, rural and underserved populations often lack access to timely radiotherapy due to the concentration of facilities in urban centers. This disparity continues to be a major healthcare equity issue across global health systems.

Radiotherapy Market Segmentation

By Product Type

• External Beam Radiotherapy (EBRT) Systems

• Internal Radiotherapy (Brachytherapy) Systems

• Systemic Radiotherapy

• Radiotherapy Accessories

• Treatment Planning Software

By Technology

• Intensity-Modulated Radiotherapy (IMRT)

• Image-Guided Radiotherapy (IGRT)

• Stereotactic Radiotherapy (SRT/SBRT)

• Proton Beam Therapy

• Intraoperative Radiotherapy (IORT)

• Adaptive Radiotherapy

By Application

• Breast Cancer

• Lung Cancer

• Prostate Cancer

• Head and Neck Cancer

• Pediatric Cancer

• Others

By End User

• Hospitals

• Cancer Treatment Centers

• Ambulatory Radiotherapy Clinics

• Academic & Research Institutes

By Region

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle East & Africa

Leading Key Players

• Varian Medical Systems

• Elekta AB

• Accuray Inc.

• Mevion Medical Systems

• IBA Group

• Siemens Healthineers

• Hitachi Ltd.

• RefleXion Medical

• ViewRay Inc.

• Isoray Medical

Recent Collaborations

• Varian Medical Systems partnered with Penn Medicine to deploy an AI-powered adaptive radiotherapy suite, enabling precision treatment in complex tumor sites.

• Elekta entered into a multi-country supply agreement with the European Commission to enhance radiotherapy access in Eastern Europe through subsidized LINAC installations.

• Accuray Inc. signed a strategic alliance with GE Healthcare to integrate imaging with the CyberKnife platform for improved real-time targeting.

• IBA Group announced collaboration with Apollo Hospitals in India to set up a new compact proton therapy center aimed at pediatric oncology.

• Mevion Medical Systems launched an R&D partnership with NRG Oncology to evaluate hypofractionated proton therapy protocols in multi-site trials.

This Market Report Will Answer the Following Questions

• How many Radiotherapy Machines are manufactured per annum globally? Who are the sub-component suppliers in different regions?

• Cost Breakdown of a Global Radiotherapy Machine and Key Vendor Selection Criteria

• Where is the Radiotherapy Machine manufactured? What is the average margin per unit?

• Market share of Global Radiotherapy Machine market manufacturers and their upcoming products

• Cost advantage for OEMs who manufacture Global Radiotherapy Machine in-house

• Key predictions for next 5 years in the Global Radiotherapy Machine market

• Average B2B Radiotherapy Machine market price in all segments

• Latest trends in the Radiotherapy Machine market, by every market segment

• The market size (both volume and value) of the Radiotherapy Machine market in 2025-2031 and every year in between

• Production breakup of the Radiotherapy Machine market, by suppliers and their OEM relationship